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Abstract:  13 
Background: The purpose of the present study was to evaluate a programme of lesion surgery 14 
carried out on patients with treatment-resistant depression (TRD). 15 
Methods: This was a retrospective study looking at clinical and psychometric data from 45 patients 16 
with TRD who had undergone bilateral stereotactic anterior capsulotomy surgery over a period of 15 17 
years, with the approval of the Mental Health Act Commission (MHAC), (37 with unipolar depression 18 
and eight with bipolar disorder). The Beck Depression Inventory (BDI) before and after surgery was 19 
used as the primary outcome measure. The Montgomery Asberg Depression Rating Scale (MADRS) 20 
was administered and cognitive aspects of executive and memory functions were also examined. We 21 
carried out a paired samples t-test on the outcome measures to determine any statistically 22 
significant change in the group as a consequence of surgery. 23 
Results: Patients improved on clinical measure of depression after surgery by -21.20 points on the 24 
BDI with a 52% change. There were no significant cognitive changes post-surgery. Six patients were 25 
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followed up in 2013 by phone interview and reported a generally positive experience. No major 26 
surgical complications occurred.  27 
Conclusions: With the limitations of an uncontrolled, observational study, our data suggest that 28 
capsulotomy can be an effective treatment for otherwise TRD. Performance on neuropsychological 29 
tests did not deteriorate.  30 
 31 
Keywords: (1) Anterior capsulotomy, (2) Depression, (3) Mood disorder, (4) Stereotactic 32 
neurosurgery, (5) Treatment resistance 33 
 34 
INTRODUCTION: 35 
Current first line treatments for depression are antidepressant medication and psychotherapy, but 36 
70% of patients do not respond to the first choice of treatment (Carvalho et al. 2014). Non-response 37 
to two or more antidepressant regimes of adequate duration and dosage is considered to denote a 38 
͞tƌeatŵeŶt-refractoƌǇ͟ depƌessioŶ (El-Hage et al. 2013). Several lines of pharmacological 39 
augmentation are available, but even with optimal drug regime and augmentation 10-30% of 40 
patients remain refractory (Rakofsky et al. 2009). Many of these patients will still get – at least 41 
temporary – relief from electroconvulsive therapy (ECT) (UK ECT Review Group, 2003). However, 42 
some patients will not respond to any of these interventions even after years of treatment 43 
(Schlaepfer et al. 2013). For such completely treatment-refractory patients, neurosurgical 44 
approaches can be considered. With such invasive approaches, which entail a lesion or implantation 45 
of a device without previous demonstration of underlying brain pathology, careful evaluation of 46 
ƌisk/ďeŶefit ƌatios, patieŶts’ ĐoŶseŶtiŶg ĐapaĐitǇ, ethiĐal aspeĐts aŶd ŶatioŶal legal ƌegulatioŶ are 47 
paramount (Nuttin et al. 2014). 48 
 49 
Over the last decade deep brain stimulation (DBS), first developed for pain, later mainly for 50 
movement disorders and then for OCD, has emerged as a possible invasive treatment for depression 51 
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(Mayberg et al. 2005).  The main DBS target sites for treating psychiatric disorders have been in the 52 
anterior limb of the internal capsule, nucleus accumbens, subgenual cingulate gyrus and the medial 53 
forebrain bundle (MFB) (Schlaepfer et al. 2013). Most studies of DBS for depression have reported 54 
responder rates between 50-60% and remission rates around 35%. However, lack of control 55 
conditions in the studies published so far, limited follow-up and a number of surgical and psychiatric 56 
side effects need to be taken into consideration when evaluating the clinical scope of this method 57 
(Schlaepfer et al. 2014; Kocabicak et al. 2015). 58 
 59 
The other surgical approach is based on stereotactic lesions to key components of the cortical-60 
subcortical networks. Stereotactic lesions of the cingulum bundle (cingulotomy) and anterior limb of 61 
the internal capsule (capsulotomy) have been performed on many hundreds of patients, mainly for 62 
the indication of OCD (Greenberg et al. 2010). The main stereotactic procedure for depression has 63 
been subcaudate tractotomy (Schoene-Bake et al. 2010). All these stereotactic procedures disrupt 64 
connections between frontal and subcortical/limbic areas of the brain (Greenberg et al. 2010; Rauch, 65 
1995). One common feature of all these approaches may be that they disrupt the MFB, which carries 66 
the dopaminergic projections from the midbrain to the frontal lobe (Schoene-Bake et al. 2010; 67 
Coenen et al. 2011).  68 
 69 
The success rates (significant improvement) for inferior frontal (subcaudate and orbitomedial) 70 
tractotomy in depression in older studies have varied between 34% and 72·7% (Göktepe et al. 1975; 71 
Hodgkiss et al. 1995; Sachdev & Sachdev, 2005). A more recent study included 33 patients with 72 
depression who had all undergone bilateral cingulotomy. About 75% of patients were classified as 73 
partial or full responders. In addition, this study included formal clinical rating scales and found a 74 
significant improvement on the BDI (Shields et al. 2008). In a cingulotomy case series of eight 75 
depressed patients from Dundee, Scotland, two patients had responded and three remitted after 76 
one year (Steele et al. 2008). 77 
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 78 
Capsulotomy for depression has been studied in fewer and smaller studies. After an initial positive 79 
report from Sweden (Herner, 1961), there was a publication gap of half a century until a group in 80 
Scotland (Christmas et al. 2011) published their series of 20 cases from 1992-1999. Their generally 81 
positive clinical impression was supported by significant and long-term improvements on clinical 82 
ratings of depression severity. However, not all measures were available for the same patients pre- 83 
and post-operatively and thus had to be imputed. Another smaller study of 8 patients was published 84 
by the Vancouver Limbic Surgery Group (Hurwitz et al. 2012) and their main finding was the 85 
reduction or abolition of suicidal ideation experienced by all the patients. In the present study we 86 
report on the other British case series of capsulotomy, covering 45 operations conducted in Cardiff, 87 
Wales, between 1993 and 2008.  88 
 89 
METHODS: 90 
Design and Patients: We carried out a retrospective study on 45 patients who underwent bilateral 91 
stereotactic anterior capsulotomy at the University Hospital of Wales (UHW), Cardiff from 1993-92 
2008 for TRD. This surgery is regulated under the Mental Health Act, 1983, which ensures that all 93 
other appropriate treatment has been exhausted. All patients had received adequate periods of 94 
treatment with a tricyclic antidepressant, an SSRI, a monoamine oxidase inhibitor, augmentation 95 
strategies and ECT (except for 2 patients) with no or insufficient benefit. Patients were referred by 96 
psychiatrists across the UK and assessed by the psychiatrist and neurosurgeon on the team and if 97 
suitable referred to the Mental Health Act Commission (MHAC), as required by UK law (Mental 98 
Health Act 1983, Section 57). Once assessed and approved by the MHAC panel (comprising a 99 
psychiatrist and two non-medical members who reviewed all the case notes and conferred with the 100 
referring consultant and with two other professionals involved with the case, and interviewed the 101 
patient, before confirming that the surgery was appropriate, and consent was freely given and fully 102 
informed) patients gave their written consent for the surgery.  103 
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Patients were discharged back to the care of the referring psychiatrist 1-2 weeks after surgery and 104 
followed up clinically at one, three,  six months and one year where possible and some (9 patients) 105 
up to 6 years for clinical assessment. Psychometric assessment was carried out in most cases 106 
between 6 and 12 months after surgery.  107 
Here we report on the audit and clinical follow-up of this capsulotomy programme. Because of the 108 
nature of the evaluation, the local Research and Development Office confirmed that this study was 109 
exempt from ethical approval. 110 
 111 
Staging of treatment resistant depression:  112 
All patients who underwent surgery were diagnosed as treatment-resistant by the clinical team. For 113 
this study we applied the Maudsley staging method which was used to determine the level of 114 
treatment resistance. This method takes into consideration the duration of the presenting 115 
depressive episode, symptom severity and treatment failures (Table 1). 116 
 117 
Surgical procedure: 118 
All patients were operated at the UHW by neurosurgeon BAS. Under general anaesthesia and with a 119 
Leksell stereotactic frame applied, computerised tomographic (CT) guidance located the targets in 120 
the anterior limbs of the internal capsules. Anatomical variation/asymmetry required bespoke 121 
coordinates. These were based on the foramen of Monro – posterior commissure (FMPC) plane. Via 122 
twist-drill holes, a stack of three (two in the first four cases) radiofrequency-generated 123 
thermocoagulative lesions was made bilaterally at a single operation. Electrode tip 4mm x 1·6mm; 124 
each lesion 75 degrees C (first 12 cases) or 80 degrees C (later cases) for 60 seconds (40 seconds in 125 
the first seven cases). The 12mm column of targets was centred on the middle third (in the axial 126 
plane) of the anterior limb of the internal capsule. The depth was increased during the series: in the 127 
later cases the deepest target was 12mm below FMPC, 5mm deeper than in the early cases. This 128 
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would have been approximately 4 to 7mm below the anterior commissure (AC) level (the relation to 129 
AC was not specifically recorded).  130 
Second Operations: 131 
Eleven of the 45 patients (of whom six are included in the psychometric analysis group; see 132 
Statistical Analysis) had a second operation. All of them had initially experienced post-operative 133 
improvement in their depression but this was lost, typically after approximately six to eight weeks. 134 
This may reflect the effects of perilesional oedema and neuropraxia and their subsequent resolution. 135 
In these 11 cases magnetic resonance (MR) scanning at six months post-operatively indicated one or 136 
more lesions, on one or both sides, to be significantly smaller than the others or even not visible, 137 
emphasised by any left-right asymmetry. These lesions were then enlarged at a second operation 138 
after obtaining MHAC approval. 139 
 140 
Clinical imaging: 141 
All patients underwent CT scanning approximately one week post-operatively for an initial 142 
assessment of lesion position, reactive oedema and any haemorrhage. Clinical MRI (T1 and T2 143 
sequences) was performed at six months follow-up (Fig. 1). 144 
 145 
Clinical and Cognitive Measures: 146 
Pre- and post-surgical data were available on the BDI, Montgomery Asberg Depression Rating Scale 147 
(MADRS) and Beck Anxiety Inventory (BAI) for subgroups of patients (see Table 2). A 148 
neuropsychological battery of tests was also administered before and after surgery for some 149 
patients. Measures used were the Wechsler Abbreviated Scale of Intelligence (WASI), Adult Memory 150 
and Information Processing Battery, test of verbal fluency and tests of attention and concentration. 151 
With a sample size of N=17 (which is our largest sample for complete cognitive data: verbal fluency 152 
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category) we had 80% power to detect medium effects on cognitive functioning (estimated required 153 
effect size for one-tailed t-test: 0.53). (See Supplementary material Table 1S for all available data on 154 
the clinical and cognitive measures). 155 
 156 
Statistical Analysis:  157 
Of the 45 operated patients demographic details, basic clinical information (Table 1) and adverse 158 
outcomes are reported for all while psychometric measures are reported for 30 patients, as no 159 
psychometric files were available for the remaining (early) cases.  160 
 161 
The time of post-surgery psychometric follow-up varied for the measures. Follow-up MADRS 162 
evaluations were performed between from one year and 4 years after surgery (except for 3 patients 163 
who had follow-up of 3-6 months). Post-surgery BDI scores were from 3-6 months for half of the 164 
patients and > 6 months follow-up for the other half of the patients. Follow-up of the other cognitive 165 
measures varied from 3 months to >1 year. 166 
For patients who had undergone a second operation where BDI pre and post-surgery scores were 167 
available (four patients) the later scores were used in the analysis.  168 
The outcome measures were analysed using the SPSS statistical package (IBM SPSS Statistics Version 169 
20). For all measures we computed % change from pre to post surgery and confidence intervals 170 
(Table 2). We also carried out a paired samples t-test on the outcome measures to determine any 171 
statistically significant change in the group as a consequence of surgery.   172 
 173 
RESULTS:  174 
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The Maudsley treatment resistant staging shows that all patients were categorised as having 175 
moderately to severely treatment-resistant depression (Table 1). It is likely that our retrospective 176 
staging process underestimated the severity of treatment resistance because information on 177 
duration of current episode and medication treatment was incomplete for the patients classified as 178 
moderately treatment resistant. 179 
We compared the duration of illness and age at time of surgery between the patients with and 180 
without psychometric measures using an independent samples t test.  There was no difference in 181 
the duration of illness (t (43) = -.94; p = .35) although those without psychometric measures were 182 
older at the time of surgery (t (43) = -2.03; p = .05). As shown in Table 1, the groups with and without 183 
psychometric data did not differ on any relevant parameter. For example, a Chi-Square test for 184 
severity of treatment refractoriness yields x2(1) = .207, p = .65 and thus no significant group 185 
difference.  186 
 187 
Even for the thirty patients for whom we had the psychometric files, data are in some cases 188 
incomplete. This was due to difficulties in motivating them to attend to the full battery of tests. 189 
Patients often requested testing to be terminated resulting in incomplete acquisition of data. Table 2 190 
gives a summary of the psychometric analysis. 191 
Clinical outcomes: 192 
Pre and post-operative BDI scores were available for 24 patients. These showed an improvement by 193 
-21.20 points (95% confidence interval -28.37 to -14.03) which represents a -52% change. A paired 194 
samples t-test (2 tailed) showed a statistically significant difference between pre and post-surgery 195 
BDI scores (t (23) = -6.12, p = .00).  196 
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Based on the BDI scores, 10 improved over 75%, 3 improved between 51 and 75%, 5 improved 197 
between 26 and 50%, 3 improved by 25% or less.  Three patients were worse than before surgery, by 198 
3%, 14% and 38%.  199 
  200 
This subgroup of 24 patients incorporated a stepwise increase in lesion depth. Initially, one lesion 201 
was placed 5mm above the FM-PC plane and two deep to it. However, over time the lesions were 202 
placed more deeply; in the later cases the highest was on the FM-PC plane, one 6mm below and one 203 
12mm below. Of the last 10 patients (those with the deepest lesion sites), improvement by more 204 
than 75% was seen after one operation in six; in the first 10 (those with the highest lesion sites) this 205 
occurred in one after one operation, and subsequently in two more following a second operation. 206 
We regard this as anecdotal evidence for an effect of lesion depth although our data do not allow for 207 
a more formal investigation of a relationship between lesion depth and clinical improvement.    208 
The BAI, available pre- and post-surgery for 13 patients, showed an improvement of 49% which was 209 
significant (t (12) = -3.27, p = .007) (Table 2).  210 
Neuropsychological outcomes: 211 
Measures of executive functions, memory, concentration and attention showed no significant 212 
change after surgery except for a small decline of digit span but very few patients (N= 5) were 213 
included in the digit span analysis (Table 2).  214 
Adverse events (Table 3):  215 
One, chronically anorectic, patient died from pneumonia within a month of surgery. No motor or 216 
sensory deficits occurred. One patient had transient focal seizures but one with medically-controlled 217 
epilepsy had no seizures after either of his two operations. Another exhibited mildly increased 218 
ŵusĐle toŶe aŶd ͞ĐogǁheeliŶg͟ iŶ ďoth upper limbs for several months, which did not recur after a 219 
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second operation 16 months later and was not related to antipsychotic medication. Some patients 220 
showed transient and mild confusion, transient incontinence of urine, fatigue and weight gain 221 
(similar to the Dundee series (Christmas et al. 2011)). Data beyond 12 months are incomplete. 222 
Phone interviews:  223 
Psychiatrist DL conducted phone interviews with six patients who responded to letters from the 224 
neurosurgeon inviting them for follow-up interviews in 2013. All had surgery for unipolar depression 225 
except one (unipolar + comorbidity). These Đoǀeƌed patieŶts’ eǆpeƌieŶĐe ďetǁeeŶ 5 aŶd 15 years 226 
post-surgery. This group reported a generally positive experience. Their mood symptoms had 227 
improved considerably, and they had required many fewer hospital admissions than before the 228 
operation, if any. Most of them did not need further ECT, although all of them continued to take 229 
antidepressant medication. Memory problems and fatigue were reported as important side effects 230 
(Table 4).    231 
 232 
DISCUSSION:  233 
The clinical outcome data from the capsulotomy series show considerable improvement of 234 
depression and anxiety symptoms in this group of patients with otherwise treatment-refractory 235 
depression. We found an improvement of 20 points on the BDI, which is similar to, or even larger 236 
than, the effects commonly observed for ECT (Feliu et al. 2008) which is regarded to be the most 237 
effective antidepressant treatment. It is thus remarkable that we found these antidepressant 238 
benefits from capsulotomy in the present sample of patients who had been refractory to ECT. 239 
Importantly, anxiety symptoms improved to a similar extent. Anecdotally, increasing lesion depth 240 
improved the outcomes.  241 
The profile of intra- and post-operative side effects was relatively favourable. There were no surgical 242 
deaths and no motor or sensory deficits. One patient had focal seizures transiently, controlled with 243 
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medication. This incidence of seizures was similar to that reported after implantation of DBS 244 
electrodes (Pouratian et al. 2011). One patient experienced transient extrapyramidal features. The 245 
only infection, in a patient with diabetes, was superficial. Transient post-operative confusion and 246 
urinary incontinence were relatively common. We did not detect deterioration in executive 247 
functions, attention and concentration or memory functions on formal psychometric testing, but 248 
cannot rule out changes in other cognitive domains (Dalgleish et al. 2004). Some patients reported 249 
fatigue, memory problems and lack of motivation, which had also been commonly reported 250 
problems in previous studies of psychiatric surgery. Although we did not have formal long-term 251 
follow-up data, the relatively high rate of memory complaints at the follow-up phone interviews 252 
suggests that cognitive deficits may develop late.   253 
Anhedonia, the core symptom of inability to experience pleasure, may be linked to a dysregulation 254 
of networks of the reward system including the MFB and the anterior thalamic radiation (ATR). Both 255 
these pathways are likely to be affected by anterior capsulotomy (Coenen et al. 2011; Bracht et al. 256 
2014). The MFB is tƌaditioŶallǇ ĐoŶsideƌed as the ŵajoƌ ͞ƌeǁaƌd pathǁaǇ͟ and the adjacent ATR may 257 
mediate the experience of ͞gƌief͟ (Coenen et al. 2011). There is also some evidence for altered 258 
structural connectivity of the MFB (Bracht et al. 2014) and ATR (Henderson et al. 2013) in 259 
depression. DBS targeting the MFB led to remarkable clinical improvements in treatment-refractory 260 
patients with major depressive disorder (Schlaepfer et al. 2013). Clinical improvement of patients 261 
with depression following surgical interventions affecting these pathways may therefore be an effect 262 
of rebalancing activation between the reward and grief system (Schlaepfer et al. 2013).  263 
Diffusion Tensor Imaging (DTI)-based  fibre-tracking enables the in vivo reconstruction of connection 264 
pathways of the human brain (Catani et al. 2002) and may therefore be used for preoperative 265 
planning and postoperative evaluation of putatively dissected pathways (Schlaepfer et al. 2013).  In 266 
three patients of our data set pre- and postoperative DTI data were available. We demonstrate and 267 
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discuss the potential use of DTI-data for future operations in a separate supplementary material (see 268 
supplementary material). 269 
  270 
Although patients with depression who do not respond to any non-invasive treatment continue to 271 
pose a considerable clinical challenge, the number of patients undergoing surgery for depression 272 
worldwide is at present very low. Cost and local availability of the procedures, evaluation of 273 
risk/benefit ratios, lack of knowledge about this treatment modality for severely refractory patients 274 
and fear of a potentially irreversible intervention are likely to contribute to this relatively low 275 
uptake. However, the recent development of several DBS procedures for depression and other 276 
mental disorders is likely to boost the interest in psychiatric surgery amongst patients and clinicians. 277 
The published evidence base for DBS (Delaloye et al. 2014) and stereotactic lesion surgery for 278 
depression is broadly similar –clinical improvements in uncontrolled studies with an acceptable side 279 
effect profile, but with little supporting evidence from randomized controlled studies. The failure of 280 
a recent DBS trial (Dougherty et al. 2015) to demonstrate superiority over sham stimulation in 281 
depression may further rekindle interest in the results of ablative surgery.  282 
The present study contributes a well-documented patient sample for the evaluation of adverse 283 
events of psychiatric surgery and suggests that capsulotomy can be effective in the long term for 284 
patients with otherwise refractory depression.   285 
 286 
Supplementary material: 287 
The supplementary material for this article can be found at 288 
https://doi.org/10.1017/S0033291716003159. 289 
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Tables: 391 
Table 1: Demographics and Treatment resistance according to the Maudsley staging method: N=45 392 
Demographics Patients with Psychometric data Patients without Psychometric data 
 Unipolar Unipolar + 
Comorbidity 
Bipolar Bipolar + 
Comorbidity 
Unipolar Unipolar + 
Comorbidity 
Bipolar 
Number of Patients 16 11 2 1 6 4 5 
Male 1 5 1 1 3 1 3 
Female 15 6 1 0 3 3 2 
Age at time of surgery in years  
Median  45.50  41  46.50  34  55.50  35.50  69  
Interquartile Range 13.50 14 18.50 0 13.25 9.75 20.50 
Last follow-up after surgery in months  
Median   30  24  36  72  66  45  39  
Interquartile Range 57 52 24 0 73.25 160.50 46 
Total duration of illness in years 
Median  20  20  16.75  10  16.50  17.50  35  
Interquartile Range 15.50 11 10.25 0 26 17 31 
History regarding Suicide  
Attempts 13 5 1 1 3 2 2 
Ideation 3 2 0 0 0 1 2 
None 0 0 0 0 0 0 0 
Not known 0 3 1 0 3 1 1 
Treatment resistance: Maudsley staging 
Symptom severity: 
Severe without 
psychosis 
13 10 2 1 6 4 4 
Severe with psychosis 3 1 0 0 0 0 1 
Duration of current episode: 
Acute 1 0 1 0 0 0 0 
Sub-acute 5 3 0 0 2 2 2 
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Footnote: All patients had had psychiatric hospital admissions but details were not available in all cases. 393 
 394 
 395 
 396 
 397 
 398 
 399 
 400 
 401 
 402 
Chronic 10 5 0 1 4 2 2 
Not known  0 3 1 0 0 0 1 
Treatment failures:  
Antidepressants (No. of medications): 
3-4 10 8 2 0 4 2 3 
5-6 6 2 0 1 2 0 1 
7-10 0 0 0 0 0 1 0 
>10 0 1 0 0 0 1 1 
Augmentation: Used 16 11 2 1 6 4 5 
Electroconvulsive 
therapy (ECT): Used 
16 9 2 1 6 4 5 
Known Psychological 
therapies 
14 7 1 1 1 1 0 
Severity category::  
Moderate 4 4 2 0 1 1 2 
Severe 12 7 0 1 5 3 3 
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Table 2: Pre and Post-surgery clinical and cognitive measures:  403 
Measures Na Pre-
surgery 
Mean  
± SE  Treatment 
change (Post - 
Pre surgery 
Mean  
± SE 95% CI % 
changeh 
t P (2-
tailed) 
Clinical Rating Scales: 
BDIb  24 41.17 2.0 -21.20 3.46 -28.37 to -14.03 -52 -6.12 .000 
BAId 13 27.38   3.04 -13.61  4.15 -22.66 to -4.56 -49 -3.27 .007 
Cognitive Measures: 
General intelligence (WASI)e: 
Verbal IQ 11 100.36  5.88       
Performance IQ 11 96.82   5.59       
Full Scale IQ 9 96.11  6.50       
Executive functions: 
Verbal fluency  17 33.76   3.64 -3.35 2.53 -8.73 to 2.02 -10 -1.32 .20 
Similarities  5 8.40   1.74 1.40 2.58 -5.76 to 8.56 17 .54 .61 
Attention and concentration: 
Speed processing 9 36.67  2.42 6.11  4.64 -4.59 to 16.81 17 1.31 .22 
Information 
processing 
12 45.83  4.98 2.58  3.21 -4.49 to 9.66 6 .80 .43 
Digit span (scaled 
scores) 
5 8  1.81 1.20  .37 .16 to 2.23 15 3.20 .03 
Digit symbol (scaled 
scores) 
6 5.83  .40 .50   .50 -.78 to 1.78 9 1.0 .36 
Memory: Immediate and delayed: 
List learning 12 41.83   3.34 -3.50  2.48 -8.96 to 1.96 -8 -1.40 .18 
Story IRf 19 27.47   2.14 1.10  3.04 -5.28 to 7.49 4 .36 .72 
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Story DRg 19 21.53   2.32 2.0  3.06 -4.44 to 8.44 9 .65 .52 
Figure IR 18 58.61   6.33 4.72  4.68 -5.16 to 14.60 8 1.00 .32 
Figure DR 18 54.39   6.34 .50  6.33 -12.86 to 13.86 1 .07 .93 
 404 
Footnote: a) N = number of patients; b) BDI = Beck Depression Inventory; d) BAI = Beck Anxiety Inventory; e) 405 
WASI = Wechsler Abbreviated Scale of Intelligence; f) IR= Immediate Recall; g) DR = Delayed Recall. 406 
h) A negative score on the clinical scales indicates an improvement and for the cognitive measures a positive 407 
score indicates an improvement. 408 
 409 
 410 
 411 
 412 
 413 
 414 
 415 
 416 
 417 
 418 
 419 
 420 
 421 
 422 
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Table 3: Frequency and duration of adverse effects: N = 45 423 
Adverse Events Patients with Psychometric data Patients without 
Psychometric data 
Total 
 Unipolar Unipolar + 
Comorbidity 
Bipolar Bipolar + 
Comorbidity 
Unipolar Unipolar + 
Comorbidity 
 
Seizures:        1 
Up to 1 week 0       
Up to 1 year 1       
>1 year 0       
Extrapyramidal S/E:       1 
Up to 1 week 0       
Up to 1 year 1       
>1 year 0       
Infectiona:       1 
Up to 1 week      1   
Up to 1 year     0   
>1 year     0   
Urinary incontinence:       24 
Up to 1 week 9 5 1 1 5 2  
Up to 1 year 1 0 0 0 0 0  
>1 year 0 0 0 0 0 0  
Confusion/disorientation:       24 
Up to 1 week 7 8 2 1 5 1  
Up to 1 year 0 0 0 0 0 0  
>1 year 0 0 0 0 0 0  
Tiredness/Fatigue:       14 
Up to 1 week 1 0 0  2 1  
Up to 1 year 4 2 2  0 1  
>1 year 0 1 0  0 0  
Short term memory 
problems: 
      10 
Up to 1 week 1 0  0 0 0  
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Up to 1 year 3 1  1 0 0  
>1 year 2 0  0 1 1  
Weight gain:       3 
Up to 1 week 0 0   1   
Up to 1 year 1 0   0   
>1 year 0 1   0   
Personality change:       2 
Up to 1 week 0       
Up to 1 year 0       
>1 year 2       
Lack of motivation:       6 
Up to 1 week 0     1  
Up to 1 year 1     0  
>1 year 4     0  
Impaired attention & 
concentration: 
      4 
Up to 1 week 0 0      
Up to 1 year 0 1      
>1 year 3 0      
 424 
Footnote: a) A superficial pin-site infection occurred in a type-1 diabetic. 425 
Data beyond 1 year are incomplete 426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
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Table 4: Interviewed patients: 434 
Age at 
interview/ 
year of 
surgery 
Pre-OP 
history 
Outcome Antidepressant 
Medication 
Side effects 
63/ 2004 
 
10 years ͞I thiŶk it ǁas ǁoŶdeƌful͟ – 
whole life has improved – she 
ďeĐaŵe a ͞diffeƌeŶt peƌsoŶ͟ as 
if ǁakiŶg fƌoŵ ͞deep sleep͟ 
 
Yes Memory 
problems 
63/ 2003 35 years ͞TƌaŶsfoƌŵed ŵǇ life͟ – does 
not feel depressed any longer – 
ďut ͞ǁould Ŷot ƌeĐoŵŵeŶd it͟ 
because of side effects 
Yes Weight gain, 
fatigue, lost 
ability to visualise 
places 
53/ 2001 12 years ͞Quite pleased͟ ďut has Ŷot 
stopped depression 
Yes Memory 
problems 
62/ 2000 3 years Depressive episodes have 
become much less frequent, 
͞highs͟ ŵoƌe fƌeƋueŶt 
Mood stabilisers Memory 
problems 
67/ 2008 23 years Depression and nihilistic 
thoughts went immediately 
Yes   Memory 
problems, lack of 
motivation 
59/ 1998 5·5 years Has made a difference, 
although benefits becoming 
smaller as time moves on – 
would have the procedure 
again 
Yes None  
  435 
 436 
Figure 1: T2 weighted MRI coronal scans: left: unoperated; right: 6 months post-surgery.  437 
 438 
 439 
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Supplementary Material:  440 
Table 1S: The pre- and post-surgical clinical and cognitive psychometric scores which were available for 30 441 
patients.  Subjects not in surgical date order. 442 
Measures Subjects 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
BDI-Pre 40 15 
(HADS) 
17 
(HADS) 
49 42 59 23 32 38 42 49  51 43 56 
BDI-Post 24 13 
(HADS) 
4 
(HADS) 
14 18 9 3 6 39 29 9 39 5 1 53 
MADRS-Pre         22       
MADRS-Post  24   14 12 5 9 4     18 40 
BAI-Pre  15 
(HADS) 
13 
(HADS) 
30 26 14 25 35 25 17 28     
BAI-Post  16 
(HADS) 
15 
(HADS) 
29 17 1 2 4 26 27 15    23 
V-IQ 118  97    126 91  95   129 76  
P-IQ 89  91    133 108  108   84 63  
FS-IQ   94    133 90  102    69  
VF-Pre  37 58 21 23 13 57 41 36 24 34     
VF-Post  24 42 12 28 23 56 35 34 29 15 28 42  21 
S-Pre 13 7  10  6 15 11  9   15 5  
S-Post 9 6    17      11   8 
SP-Pre    48 5 30 42  33 41 31     
SP-Post    43  60 58 50 28 29 30 36 47 35 41 
IP-Pre    50 29 35 79 44 28 38 23     
IP-Post    60 30 54 101 46 30 40 10 65 60 33 34 
DS-Pre 12 5 7 6  10       6 6  
DS-Post  5 9   11      13   8 
DSy-Pre 6 6 7      5     2  
DSy-Post 5 6 9             
LL-Pre    39  29 56 49 36 38    20  
LL-Post    30 43 35 40 35 34 40   40 30 37 
S_IR-Pre 36 29 28 32 5 10 35 24 18 24 26  30 34  
S_IR-Post 39 19 32 14 38 30 22 44 26 25 10 39 23 29 35 
S_DR-Pre 31 21 24 22 3 3 35 16 16 16 15  21 23  
S_DR-Post 36 6 30 0 37 20 25 38 24 21 2 36 25 21 26 
F_IR-Pre 49 75 38 67 3 55 90 75 41 96 26  51 56  
F_IR-Post 33 90 53 63 70 65 97 84 34 92 21 61 80 38 48 
F_DR-Pre 59 43 38 63 0 60 90 59 42 93 25  36 38  
F_DR_Post 33 38 44 0 70 61 97 68 34 95 18 50 81 33 56 
Measures Subjects 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
BDI-Pre 42  26 32 56 37 37 25 47 29 52 34 30  42 
BDI-Post 23 40 36 24 54 42 25  5 5 25 25 1  4 
MADRS-Pre  40          25   23 
MADRS-Post 11 21 21 11     13  22   12 6 
BAI-Pre 50  35   41  0 40 12     18 
BAI-Post 2  23 36 17 18 25   4     11 
V-IQ 82     107    111   72   
P-IQ 102     97    110   80   
FS-IQ 88     102    113   74   
VF-Pre 19  11 39  45  17  51   18  47 
VF-Post 22  12 36 24 21 38   44  23 33  51 
S-Pre 9  4   12  6 12 38   4   
S-Post  11    11       6   
SP-Pre       40 54  25     40 
SP-Post       44   47     46 
IP-Pre 61      65 44  38     60 
IP-Post 50      53   45     62 
DS-Pre 8  6   14  8     4   
DS-Post  13    15 6      6   
DSy-Pre 10  4   6  2     6   
DSy-Post   4   6 6      8   
LL-Pre 43  33     39  50 49    60 
LL-Post 32  24       55 42    63 
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S_IR-Pre 20  25 44  36  17  36   32  42 
S_IR-Post 21 39 18  10 25 24   41   40  47 
S_DR-Pre 14  18   28  16  37   25  41 
S_DR-Post 6 36 15 44 7 23 26   38   35  45 
F_IR-Pre 95  18   53  97     84  83 
F_IR-Post 94  27 75 30 46 59      67  85 
F_DR-Pre 95  18   58  89     78  84 
F_DR_Post 95  28 83 26 46 59      67  80 
 443 
Footnote: Footnote: BDI = Beck Depression Inventory; HADS = Hospital anxiety and depression scale (these 444 
scores were available for 2 patients and replace the BDI (HADS depression scale) and BAI (HADS anxiety scale) 445 
where indicated); MADRS = Montgomery Asberg Depression Rating Scale; BAI = Beck Anxiety Inventory; I = 446 
Imputed; V = Verbal; P = Performance; FS = Full Scale; VF = Verbal Fluency; S = Similarities; SP = Speed 447 
Processing; IP = Information Processing; DS = Digit Span; DSy = Digit Symbol; LL = List Learning; S = Story; F = 448 
Figure; IR= Immediate Recall; DR = Delayed Recall. 449 
  450 
Diffusion Tensor Imaging: 451 
The potential use of DTI-based fibre tracking 452 
Diffusion Tensor Imaging (DTI)-based fibre-tracking enables the in vivo reconstruction of connection 453 
pathways of the human brain (Catani et al. 2002). Previous research suggests that white matter 454 
microstructure of the medial forebrain bundle (MFB) and the anterior thalamic radiation (ATR), 455 
pathways that are likely to be interrupted during anterior capsulotomy, are altered in depression (Jia 456 
et al. 2014; Bracht et al. 2014). Based on a recent review these changes are most pronounced in 457 
MDD patients with severe/ treatment-resistant depression (Bracht et al. 2015). Thus the MFB and 458 
ATR may be of particular relevance regarding the clinical effects of anterior capsulotomy. Pre-459 
operative DTI-based identification of target fibre tracts that may underlie depression 460 
symptomatology may therefore potentially represent an important step forward in psychiatric 461 
surgery. Furthermore, DTI fibre tracking may be used for evaluation of surgical outcome, and to link 462 
side effects to the lesioning of specific pathways. In three patients pre- and postoperative DTI data 463 
were available and analyzed.  464 
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Methods: 465 
Diffusion Tensor Imaging (DTI):  466 
Data were acquired on a clinical GE Medical System 1·5 Tesla scanner with the following parameters: 467 
24 diffusion encoding directions with a b-value of 1000 s/mm2, 1B0 image without diffusion 468 
weighting, 30 slices, voxel size 2x2x5 mm. Pre and post diffusion-MRI data were available for three 469 
patients.   470 
Imaging Analysis:  471 
Data were pre-processed and analysed using the software package ExploreDTI (Leemans et al. 2009). 472 
Regions of interest of connection pathways were chosen from the automated anatomical labelling 473 
(AAL) atlas (Tzourio-Mazoyer et al. 2002), implemented in ExploreDTI (Leemans et al. 2009). We 474 
hypothesized the thalamo-orbitofrontal cortex (OFC) connection pathway to be interrupted by the 475 
operation. For reconstruction of this pathway the thalamus and Brodmann areas 10 and 11 were 476 
chosen as seed regions. The thalamo-primary motor cortex (PMC) connection was reconstructed as a 477 
comparison tract which we did not expect to be affected by the operation. These two connection 478 
pathways were separately reconstructed for individual pre-surgical and post-surgical datasets. 479 
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Results:480 
 481 
Figure 1S: Fibre connections between the thalamus and orbitofrontal cortex pre and post-surgery 482 
(left panel) and fibre connections between the thalamus and primary motor cortex pre and post-483 
surgery (right panel). BDI clinical scores for the 3 patients: Row 1: Pre-42, Post-4, 90% change; Row 484 
2: Pre-42, Post-29, 31% change; Row 3: Pre-49, Post-9, 82% change. 485 
 486 
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In all pre-surgery DTI scans both bilateral thalamo-OFC connection pathways travelling through the 487 
anterior limb in the internal capsule and bilateral thalamo-PMC pathways running through the 488 
cortico-spinal tract could be identified reliably.  489 
In the post-operative DTI scans in one participant no fibres connecting thalamus and OFC could be 490 
identified (row 1, Figure 1B). In two participants DTI-fibre-tracking revealed sparse unilateral 491 
connection pathways between the OFC and the thalamus running through the external capsule (row 492 
2 and row 3, Figure 1B). These fibres had not been reconstructed before the operation. Bilateral 493 
thalamo-PMC connections remained unchanged in comparison to the pre-operative DTI scan. 494 
Discussion 495 
At present diffusion MRI is the only available method for in vivo reconstruction of fibre pathways 496 
and thus offers unique opportunities in psychiatric surgery and stimulation studies. Our DTI-fibre 497 
tracking results support the assumption that pathways connecting the thalamus and OFC have been 498 
successfully interrupted. DTI fibre tracking results of the thalamo-PMC comparison pathway 499 
remained unchanged after the operation, indicating that the surgical intervention had no effect on 500 
more posterior thalamo-cortical connections. 501 
We suggest that DTI-fibre tracking will find more widespread use in future applications of psychiatric 502 
surgery. It may be used to reconstruct pathways before the operation and serve as guidance to 503 
specifically modulate pathways of interest; postoperative DTI-fibre tracking may validate surgery 504 
outcome; follow-up studies could link the lesioning of specific pathways to treatment outcome and 505 
side effects. This may contribute to the development of more specific and less invasive surgery, 506 
potentially being associated with fewer side effects. DTI-based tractography has already informed 507 
new protocols for DBS (Coenen et al. 2011) and is being used to localize stimulation targets 508 
(Schlaepfer et al. 2013).  509 
 510 
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